stock price for ionis
NEW YORK (TheStreet) -- Shares of Ionis Pharmaceuticals (IONS) are plummeting by 31.96% to $23.99 on heavy trading volume Thursday morning, after the company's partner GlaxoSmithKline (GSK) decided against initiating a phase-three study for Ionis-TTR, which the companies have been co-developing.
52 Week High/Low 52 Week High is the highest sales price the stock has achieved during the regular trading hours during the most recent 52 week period. 52 Week Low is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period. $ 9.75 / $ 8.21. Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent.